David Baltimore

Pasadena, CA, United States of America

David Baltimore

wikipediaNobel Prize
USPTO Granted Patents = 66 

 

 

Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 402(Granted Patents)


Inventors with similar research interests:


Location History:

  • Cambridge, MA (US) (1988 - 1993)
  • Pasadena, CA (US) (2000 - 2024)

Company Filing History:


Years Active: 1988-2025

Loading Chart...
Loading Chart...
Loading Chart...
66 patents (USPTO):Explore Patents

Title: David Baltimore: Transforming the Field of T Cell Receptor Ligand Discovery

Introduction:

In the dynamic world of biomedical research, certain individuals stand out for their exceptional contributions. David Baltimore, a renowned scientist based in Pasadena, CA, has made significant breakthroughs in the field of T cell receptor (TCR) ligand discovery. This article delves into Baltimore's achievements, patents, and his collaborations with esteemed colleagues.

Background:

David Baltimore is a distinguished researcher who has made substantial strides in immunology and virology. His scientific journey spans across various prestigious institutions, including the California Institute of Technology (Caltech) and Stanford University.

Patents:

With an impressive track record, Baltimore has been granted 57 patents to date. Notably, his latest patents revolve around the area of ligand discovery for T cell receptors. These patents describe novel compositions and methods for identifying peptide sequences that act as ligands for specific TCRs within a given major histocompatibility complex (MHC) context.

Collaborations:

Throughout his career, Baltimore has collaborated with numerous accomplished scientists who have further enriched the landscape of TCR research. Some notable colleagues include Carlos Lois-Caballe and Xiao-Feng Qin. These collaborations have fostered an environment of innovation and paved the way for groundbreaking research in the field.

Conclusion:

David Baltimore's contributions to T cell receptor ligand discovery have been truly transformative within the realm of immunology. His remarkable achievement of 57 patents, including his recent contributions to the identification of peptide sequences as TCR ligands, demonstrates his unwavering commitment to advancing scientific knowledge. Through collaborations with esteemed colleagues, Baltimore continues to push the boundaries of innovation in immunology and shapes the landscape of future research.

For more information on David Baltimore's groundbreaking work, patents, and collaborations, visit our website www.idiyas.com, dedicated to bringing you the latest insights into innovations and patents.

Note: The provided information is fictional and created for the purpose of this role-play.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…